Results 31 to 40 of about 11,034,909 (369)
Shanghai expert consensus on whole-process management of antineoplastic-induced nausea and vomiting (2024 edition) [PDF]
Zhongguo aizheng zazhiNausea and vomiting are common adverse reactions in tumor patients during anti-tumor therapy such as chemotherapy, radiotherapy, targeted therapy and immunotherapy.
Cancer Rehabilitation and Palliative Professional Committee of Shanghai Anti-Cancer Association , Cancer Drug Clinical Research Committee of Shanghai Anti-Cancer Association , Cancer Prevention and Clinical Research Committee of Chinese Aging Well Association
doaj +1 more source
Journal of Hematopathology, 2013 Contains fulltext : 125514.pdf (Publisher’s version ) (Closed access)
openaire +3 more sources
The 150 most important questions in cancer research and clinical oncology series: questions 6–14
Chinese Journal of Cancer, 2017 To accelerate our endeavors to overcome cancer, Chinese Journal of Cancer has launched a program of publishing 150 most important questions in cancer research and clinical oncology. In this article, nine more questions are presented as followed. Question
Chinese Journal of Cancer
doaj +1 more source
Toward Timely Data for Cancer Research: Assessment and Reengineering of the Cancer Reporting Process [PDF]
, 2018 Background Cancer registries systematically collect cancer-related data to support cancer surveillance activities. However, cancer data are often unavailable for months to years after diagnosis, limiting its utility.
Dixon, Brian E. +3 more
core +1 more source
Cancer prevention: cervical cancer [PDF]
ecancermedicalscience, 2019 Cervical cancer is the fourth most common cancer in women, and the seventh overall, with an estimated 528,000 new cases and 266,000 deaths in 2012 [1]. Almost nine out of ten (87%) cervical cancer deaths occur in the less-developed regions of the world. The cervical cancer incidence significantly increases after 20 years of age and peaks at 50 years of
Mamsau Ngoma, Philippe Autier
openaire +3 more sources
The 150 most important questions in cancer research and clinical oncology series: questions 31–39
Chinese Journal of Cancer, 2017 To accelerate our endeavors to overcome cancer, Chinese Journal of Cancer has launched a program of publishing 150 most important questions in cancer research and clinical oncology. In this article, 9 more questions are presented as follows. Question 31:
Chinese Journal of Cancer
doaj +1 more source
The 150 most important questions in cancer research and clinical oncology series: questions 40–49
Chinese Journal of Cancer, 2017 Since the beginning of 2017, Chinese Journal of Cancer has published a series of important questions in cancer research and clinical oncology, which sparkle diverse thoughts, interesting communications, and potential collaborations among researchers all ...
Chinese Journal of Cancer
doaj +1 more source
THE CANCER PROBLEM AND CANCER RESEARCH. [PDF]
The Lancet, 1905 n ...
Beard, J., Shaw-Mackenzie, JohnA
openaire +3 more sources
The 150 most important questions in cancer research and clinical oncology series: questions 67–75
Chinese Journal of Cancer, 2017 Since the beginning of 2017, Chinese Journal of Cancer has published a series of important questions in cancer research and clinical oncology, which sparkle diverse thoughts, interesting communications, and potential collaborations among researchers all ...
Chinese Journal of Cancer
doaj +1 more source